EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $511,000 | -65.4% | 60,008 | -64.0% | 0.00% | -72.7% |
| Q1 2021 | $1,476,000 | -41.0% | 166,726 | -18.1% | 0.01% | -50.0% |
| Q4 2020 | $2,503,000 | +5.8% | 203,644 | -29.9% | 0.02% | -12.0% |
| Q3 2020 | $2,366,000 | +34.6% | 290,698 | +58.7% | 0.02% | +31.6% |
| Q2 2020 | $1,758,000 | +207.9% | 183,120 | +118.1% | 0.02% | +171.4% |
| Q1 2020 | $571,000 | +79.6% | 83,979 | +293.2% | 0.01% | +133.3% |
| Q4 2019 | $318,000 | +43.2% | 21,360 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $222,000 | -11.6% | 21,660 | +45.0% | 0.00% | -40.0% |
| Q1 2016 | $251,000 | – | 14,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |